Gene · 5336
Papers3,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-canonical non-genomic morphogen signaling in anucleate platelets: a critical determinant of prothrombotic function in circulation. | Cell Commun Signal | 2024 | 38172855 | PubTator, text mining | PubMed |
| Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets. | Signal Transduct Target Ther | 2024 | 38172098 | PubTator, text mining | PubMed |
| Causal effects of gut microbiota on sepsis and sepsis-related death: insights from genome-wide Mendelian randomization, single-cell RNA, bulk RNA sequencing, and network pharmacology. | J Transl Med | 2024 | 38167131 | PubTator, text mining | PubMed |
| Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL. | Blood Adv | 2024 | 38163317 | PubTator, text mining | PubMed |
| A review of sources, pathways, and toxic effects of human exposure to benzophenone ultraviolet light filters. | Eco Environ Health | 2024 | 38162868 | PubTator, text mining | PubMed |
| Scaffold protein SH3BP2 signalosome is pivotal for immune activation in nephrotic syndrome. | JCI Insight | 2024 | 38127456 | PubTator, text mining | PubMed |
| Human PLCG2 haploinsufficiency results in a novel NK cell immunodeficiency. | J Allergy Clin Immunol | 2024 | 38123021 | PubTator, text mining | PubMed |
| Bioinformatics analyses and experimental validation of the role of phagocytosis in low-grade glioma. | Environ Toxicol | 2024 | 38112449 | PubTator, text mining | PubMed |
| The hypermorphic PLCγ2 S707Y variant dysregulates microglial cell function - Insight into PLCγ2 activation in brain health and disease, and opportunities for therapeutic modulation. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38061598 | PubTator, text mining | PubMed |
| Overcoming Resistance in Chronic Lymphocytic Leukemia-Maybe Less Is More? | Clin Cancer Res | 2024 | 38055246 | PubTator, text mining | PubMed |
| Phosphatidylserine synthesis controls oncogenic B cell receptor signaling in B cell lymphoma. | J Cell Biol | 2024 | 38048228 | PubTator, text mining | PubMed |
| Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax. | Clin Cancer Res | 2024 | 37955424 | PubTator, text mining | PubMed |
| Novel PI(3)K-p85α/p110δ-ITK-LAT-PLC-γ2 and Fyn-ADAP-Carma1-TAK1 Pathways Define Reverse Signaling via FasL. | Crit Rev Immunol | 2024 | 37947072 | PubTator, text mining | PubMed |
| Signaling pathways regulating the extracellular digestion of lipoprotein aggregates by macrophages. | Mol Biol Cell | 2024 | 37910189 | PubTator, text mining | PubMed |
| PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants. | J Allergy Clin Immunol | 2024 | 37769878 | PubTator, text mining | PubMed |
| Bruton's Tyrosine Kinase Inhibitors with Distinct Binding Modes Reveal Differential Functional Impact on B-Cell Receptor Signaling. | Mol Cancer Ther | 2024 | 37735104 | PubTator, text mining | PubMed |
| Human PLCG2 haploinsufficiency results in a novel natural killer cell immunodeficiency. | J Allergy Clin Immunol | 2024 | 37714437 | PubTator, text mining | PubMed |
| Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapies. | Haematologica | 2024 | 37706363 | PubTator, text mining | PubMed |
| Endocytosis and Alzheimer's disease. | Geroscience | 2024 | 37646904 | PubTator, text mining | PubMed |
| Targeting T-cell integrins in autoimmune and inflammatory diseases. | Clin Exp Immunol | 2024 | 37556361 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5336/papers?page=13